Tyrosine kinase inhibitors: rationale, mechanisms of action, and implications for drug resistance.

Busse, D

Tyrosine kinase inhibitors: rationale, mechanisms of action, and implications for drug resistance. [electronic resource] - Seminars in oncology Oct 2001 - 47-55 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review

0093-7754

10.1016/s0093-7754(01)90282-9 doi


Animals
Antineoplastic Agents--pharmacology
Breast Neoplasms--drug therapy
Cell Cycle--drug effects
Clinical Trials as Topic
Drug Evaluation, Preclinical
Drug Resistance, Neoplasm
Enzyme Inhibitors--pharmacology
Humans
Ligands
Neoplasms, Glandular and Epithelial--drug therapy
Protein-Tyrosine Kinases--antagonists & inhibitors
Receptor Protein-Tyrosine Kinases--antagonists & inhibitors
Receptor, ErbB-2--antagonists & inhibitors
Signal Transduction--drug effects